The upregulation of PARP1 also leads to a drastic reduction of NAD+ levels, affecting ATP production and cell functions, which can lead to the development of other conditions such as diabetes, neurodegenerative diseases, and viral infections [32, 33]. The gene discussed is PARP1; the disease is neurodegenerative disease.